Share Price and Basic Stock Data
Last Updated: November 7, 2025, 4:15 pm
| PEG Ratio | 1.14 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Continental Seeds and Chemicals Ltd operates in the seeds, tissue culture, and biotechnology sector, with a current market capitalization of ₹25.8 Cr. The company’s share price is ₹23.4, reflecting a P/E ratio of 43.6, which is relatively high compared to typical industry norms. The company reported sales of ₹75.41 Cr for the fiscal year ending March 2023, showing a decline from ₹97.88 Cr in March 2022. However, the trailing twelve months (TTM) sales rose to ₹90.75 Cr by March 2025. Quarterly sales figures demonstrate fluctuations, with ₹39.24 Cr in September 2023 and an increase to ₹58.44 Cr in March 2024. The operating profit margin (OPM) was notably low at 3.01%, indicating challenges in cost management. The company’s revenue from operations per share stood at ₹71.44 in March 2025, a decrease from ₹97.65 in March 2024. Overall, while the revenue trajectory has shown some recovery, the company remains vulnerable to market dynamics and cost pressures.
Profitability and Efficiency Metrics
Continental Seeds and Chemicals Ltd reported a net profit of ₹1.83 Cr for the fiscal year ending March 2025, reflecting a significant improvement from a mere ₹0.02 Cr in March 2023. The company’s return on equity (ROE) stood at 2.87%, which is low compared to industry benchmarks, indicating that the company is not effectively generating returns for its shareholders. The return on capital employed (ROCE) was recorded at 4.24%, which is also below average for the sector. The interest coverage ratio (ICR) of 8.99x suggests that the company is comfortably managing its interest obligations, a positive indicator of financial health. However, the cash conversion cycle (CCC) was at 64.99 days, indicating inefficiencies in managing working capital. The net profit margin of 2.01% for March 2025 remains low compared to industry averages, signaling potential areas for operational improvement.
Balance Sheet Strength and Financial Ratios
The balance sheet of Continental Seeds and Chemicals Ltd shows total assets of ₹36.62 Cr as of March 2025, with total liabilities at ₹26.54 Cr. The company has reported reserves of ₹15.68 Cr, a substantial increase from ₹2.30 Cr in March 2023, indicating stronger retained earnings. The borrowings have decreased to ₹3.91 Cr, improving the debt-to-equity ratio to 0.11, which is favorable compared to typical industry levels. The current ratio stood at 2.82, suggesting that the company has sufficient short-term assets to cover its liabilities, while the quick ratio of 1.35 also indicates good liquidity. Financial ratios such as the price-to-book value (P/BV) at 1.30x and enterprise value (EV) to net operating revenue at 0.44x reflect a reasonable valuation compared to peers, although the high P/E ratio may suggest an overvaluation in the current market conditions.
Shareholding Pattern and Investor Confidence
As of March 2025, the shareholding pattern of Continental Seeds and Chemicals Ltd reveals significant promoter ownership at 56.91%, down from 72.27% in previous years, indicating a gradual dilution of control. Foreign institutional investors (FIIs) have increased their stake to 12.88%, which reflects growing confidence from external investors. The public’s shareholding is at 43.09%, which has increased from 27.73% in March 2022, suggesting rising interest from retail investors. The number of shareholders has also grown to 355, indicating improved market interest. However, the decline in promoter shareholding could raise concerns about management’s long-term commitment. High promoter ownership is often seen as a sign of stability, and the significant reduction may lead to skepticism among potential investors regarding future governance and strategic decisions.
Outlook, Risks, and Final Insight
The outlook for Continental Seeds and Chemicals Ltd hinges on its ability to enhance operational efficiency and improve profitability metrics. While the company has demonstrated a rebound in sales and net profit figures, persistent low margins and high P/E ratios pose risks for investors. The growing interest from FIIs and the public can serve as a positive indicator, but the decreasing promoter stake may create uncertainty. Potential risks include volatility in raw material prices, regulatory challenges in the biotechnology sector, and competition from larger players. In scenarios where operational efficiencies are realized, and profitability improves, the company may see a favorable shift in investor sentiment. Conversely, failure to address cost structures and manage market dynamics effectively could lead to further declines in profitability and shareholder confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Continental Seeds and Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 9.43 Cr. | 30.9 | 108/27.2 | 94.3 | 12.8 | 0.00 % | 11.8 % | 9.68 % | 10.0 |
| Genesis IBRC India Ltd | 231 Cr. | 178 | 178/16.6 | 66.4 | 6.56 | 0.00 % | 51.6 % | 51.6 % | 10.0 |
| Shreeoswal Seeds & Chemicals Ltd | 138 Cr. | 15.1 | 23.7/10.7 | 10.2 | 4.78 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 325 Cr. | 171 | 239/138 | 7.09 | 341 | 1.17 % | 7.35 % | 6.77 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 23.6 Cr. | 21.4 | 47.5/20.8 | 39.9 | 25.8 | 0.00 % | 4.24 % | 2.87 % | 10.0 |
| Industry Average | 231.33 Cr | 83.28 | 43.58 | 78.19 | 0.23% | 16.97% | 15.87% | 8.40 |
All Competitor Stocks of Continental Seeds and Chemicals Ltd
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Sep 2022 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.27 | 62.65 | 38.33 | 57.07 | 38.33 | 57.07 | 39.24 | 58.44 | 43.53 | 47.22 |
| Expenses | 24.72 | 61.78 | 37.65 | 56.36 | 37.65 | 56.36 | 37.57 | 60.18 | 42.16 | 45.80 |
| Operating Profit | 0.55 | 0.87 | 0.68 | 0.71 | 0.68 | 0.71 | 1.67 | -1.74 | 1.37 | 1.42 |
| OPM % | 2.18% | 1.39% | 1.77% | 1.24% | 1.77% | 1.24% | 4.26% | -2.98% | 3.15% | 3.01% |
| Other Income | 0.12 | 0.19 | 0.13 | 0.12 | 0.13 | 0.12 | 0.16 | 4.21 | 1.65 | 0.66 |
| Interest | 0.22 | 0.21 | 0.24 | 0.30 | 0.24 | 0.30 | 0.24 | 0.29 | 0.22 | 0.18 |
| Depreciation | 0.25 | 0.19 | 0.22 | 0.39 | 0.22 | 0.39 | 1.47 | 1.50 | 1.29 | 1.20 |
| Profit before tax | 0.20 | 0.66 | 0.35 | 0.14 | 0.35 | 0.14 | 0.12 | 0.68 | 1.51 | 0.70 |
| Tax % | 90.00% | 3.03% | 31.43% | 0.00% | 31.43% | 0.00% | -8.33% | 20.59% | 22.52% | 4.29% |
| Net Profit | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.17 | 0.66 |
| EPS in Rs | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.06 | 0.60 |
Last Updated: August 1, 2025, 10:35 pm
Below is a detailed analysis of the quarterly data for Continental Seeds and Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 47.22 Cr.. The value appears strong and on an upward trend. It has increased from 43.53 Cr. (Sep 2024) to 47.22 Cr., marking an increase of 3.69 Cr..
- For Expenses, as of Mar 2025, the value is 45.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.16 Cr. (Sep 2024) to 45.80 Cr., marking an increase of 3.64 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.42 Cr.. The value appears strong and on an upward trend. It has increased from 1.37 Cr. (Sep 2024) to 1.42 Cr., marking an increase of 0.05 Cr..
- For OPM %, as of Mar 2025, the value is 3.01%. The value appears to be declining and may need further review. It has decreased from 3.15% (Sep 2024) to 3.01%, marking a decrease of 0.14%.
- For Other Income, as of Mar 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 1.65 Cr. (Sep 2024) to 0.66 Cr., marking a decrease of 0.99 Cr..
- For Interest, as of Mar 2025, the value is 0.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.22 Cr. (Sep 2024) to 0.18 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Mar 2025, the value is 1.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.29 Cr. (Sep 2024) to 1.20 Cr., marking a decrease of 0.09 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.70 Cr.. The value appears to be declining and may need further review. It has decreased from 1.51 Cr. (Sep 2024) to 0.70 Cr., marking a decrease of 0.81 Cr..
- For Tax %, as of Mar 2025, the value is 4.29%. The value appears to be improving (decreasing) as expected. It has decreased from 22.52% (Sep 2024) to 4.29%, marking a decrease of 18.23%.
- For Net Profit, as of Mar 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Sep 2024) to 0.66 Cr., marking a decrease of 0.51 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.60. The value appears to be declining and may need further review. It has decreased from 1.06 (Sep 2024) to 0.60, marking a decrease of 0.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 5:47 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.56 | 57.69 | 58.07 | 58.19 | 81.62 | 82.10 | 87.68 | 95.36 | 97.88 | 75.41 | 97.68 | 90.75 |
| Expenses | 54.49 | 56.80 | 57.28 | 56.71 | 79.77 | 80.37 | 86.24 | 93.88 | 96.10 | 71.50 | 97.74 | 87.96 |
| Operating Profit | 0.07 | 0.89 | 0.79 | 1.48 | 1.85 | 1.73 | 1.44 | 1.48 | 1.78 | 3.91 | -0.06 | 2.79 |
| OPM % | 0.13% | 1.54% | 1.36% | 2.54% | 2.27% | 2.11% | 1.64% | 1.55% | 1.82% | 5.18% | -0.06% | 3.07% |
| Other Income | 0.30 | 0.09 | 0.06 | 0.05 | 0.09 | 0.10 | 0.31 | 0.26 | 0.24 | 0.16 | 4.37 | 2.30 |
| Interest | 0.00 | 0.36 | 0.52 | 0.62 | 0.62 | 0.70 | 0.45 | 0.64 | 0.39 | 0.53 | 0.54 | 0.40 |
| Depreciation | 0.08 | 0.24 | 0.10 | 0.20 | 0.26 | 0.27 | 0.44 | 0.61 | 1.25 | 3.52 | 2.97 | 2.49 |
| Profit before tax | 0.29 | 0.38 | 0.23 | 0.71 | 1.06 | 0.86 | 0.86 | 0.49 | 0.38 | 0.02 | 0.80 | 2.20 |
| Tax % | 27.59% | 31.58% | 26.09% | 33.80% | 32.08% | 45.35% | 25.58% | 22.45% | 47.37% | 50.00% | 16.25% | 16.82% |
| Net Profit | 0.22 | 0.27 | 0.16 | 0.47 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.83 |
| EPS in Rs | 1.05 | 1.29 | 0.76 | 2.24 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.66 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.73% | -40.74% | 193.75% | 53.19% | -36.11% | 41.30% | -43.08% | -48.65% | -89.47% | 3250.00% | 173.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | -63.47% | 234.49% | -140.56% | -89.30% | 77.42% | -84.38% | -5.57% | -40.83% | 3339.47% | -3076.87% |
Continental Seeds and Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 41% |
| TTM: | 126% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 40% |
| 1 Year: | -64% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: October 10, 2025, 1:51 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.25 | 1.25 | 1.25 | 6.00 | 6.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 12.70 |
| Reserves | 3.50 | 3.76 | 3.92 | 4.41 | 4.59 | 5.03 | 1.68 | 2.03 | 2.23 | 2.30 | 2.69 | 15.68 |
| Borrowings | 0.00 | 2.59 | 4.01 | 4.63 | 3.75 | 3.68 | 4.75 | 7.62 | 5.65 | 6.17 | 5.45 | 3.91 |
| Other Liabilities | 0.68 | 1.61 | 3.03 | 2.38 | 22.11 | 14.10 | 5.89 | 13.77 | 13.77 | 12.24 | 8.40 | 4.33 |
| Total Liabilities | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 |
| Fixed Assets | 0.73 | 0.50 | 0.40 | 1.56 | 1.31 | 1.67 | 3.15 | 4.55 | 20.80 | 18.18 | 15.66 | 15.29 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.41 | 4.73 | 11.82 | 0.00 | 0.00 | 0.49 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.70 | 8.71 | 11.81 | 11.11 | 35.14 | 25.73 | 14.44 | 17.05 | 10.85 | 12.53 | 10.39 | 21.33 |
| Total Assets | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 |
Below is a detailed analysis of the balance sheet data for Continental Seeds and Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 12.70 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 12.70 Cr., marking an increase of 2.70 Cr..
- For Reserves, as of Mar 2025, the value is 15.68 Cr.. The value appears strong and on an upward trend. It has increased from 2.69 Cr. (Mar 2024) to 15.68 Cr., marking an increase of 12.99 Cr..
- For Borrowings, as of Mar 2025, the value is 3.91 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.45 Cr. (Mar 2024) to 3.91 Cr., marking a decrease of 1.54 Cr..
- For Other Liabilities, as of Mar 2025, the value is 4.33 Cr.. The value appears to be improving (decreasing). It has decreased from 8.40 Cr. (Mar 2024) to 4.33 Cr., marking a decrease of 4.07 Cr..
- For Total Liabilities, as of Mar 2025, the value is 36.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.54 Cr. (Mar 2024) to 36.62 Cr., marking an increase of 10.08 Cr..
- For Fixed Assets, as of Mar 2025, the value is 15.29 Cr.. The value appears to be declining and may need further review. It has decreased from 15.66 Cr. (Mar 2024) to 15.29 Cr., marking a decrease of 0.37 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.49 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 0.49 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 21.33 Cr.. The value appears strong and on an upward trend. It has increased from 10.39 Cr. (Mar 2024) to 21.33 Cr., marking an increase of 10.94 Cr..
- For Total Assets, as of Mar 2025, the value is 36.62 Cr.. The value appears strong and on an upward trend. It has increased from 26.54 Cr. (Mar 2024) to 36.62 Cr., marking an increase of 10.08 Cr..
Notably, the Reserves (15.68 Cr.) exceed the Borrowings (3.91 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.07 | -1.70 | -3.22 | -3.15 | -1.90 | -1.95 | -3.31 | -6.14 | -3.87 | -2.26 | -5.51 | -1.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.95 | 9.55 | 42.68 | 37.89 | 111.80 | 57.26 | 13.28 | 33.87 | 9.14 | 17.81 | 12.74 | 24.45 |
| Inventory Days | 1.97 | 32.35 | 19.39 | 21.47 | 16.45 | 16.50 | 21.19 | 21.95 | 23.75 | 16.75 | 13.09 | 45.72 |
| Days Payable | 0.07 | 5.34 | 13.72 | 0.13 | 95.65 | 59.47 | 12.83 | 33.71 | 73.24 | 33.22 | 9.56 | 5.19 |
| Cash Conversion Cycle | 6.85 | 36.57 | 48.35 | 59.23 | 32.60 | 14.29 | 21.63 | 22.11 | -40.36 | 1.34 | 16.27 | 64.99 |
| Working Capital Days | 13.31 | 37.52 | 33.25 | 34.56 | 22.14 | 10.94 | 9.57 | -14.20 | -34.31 | -7.31 | -4.07 | 48.67 |
| ROCE % | 6.25% | 11.98% | 8.94% | 13.76% | 13.64% | 10.95% | 7.77% | 6.54% | 4.26% | 3.30% | -10.00% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Diluted EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Cash EPS (Rs.) | 3.40 | 3.64 | 3.54 | 1.44 | 0.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Revenue From Operations / Share (Rs.) | 71.44 | 97.65 | 75.39 | 97.86 | 95.37 |
| PBDIT / Share (Rs.) | 2.80 | 1.13 | 4.12 | 2.04 | 1.69 |
| PBIT / Share (Rs.) | 0.83 | -1.84 | 0.60 | 0.79 | 1.08 |
| PBT / Share (Rs.) | 1.73 | 0.79 | 0.02 | 0.37 | 0.48 |
| Net Profit / Share (Rs.) | 1.44 | 0.66 | 0.01 | 0.18 | 0.37 |
| PBDIT Margin (%) | 3.92 | 1.15 | 5.46 | 2.08 | 1.77 |
| PBIT Margin (%) | 1.17 | -1.88 | 0.79 | 0.81 | 1.12 |
| PBT Margin (%) | 2.42 | 0.81 | 0.02 | 0.38 | 0.51 |
| Net Profit Margin (%) | 2.01 | 0.68 | 0.02 | 0.19 | 0.39 |
| Return on Networth / Equity (%) | 6.43 | 5.24 | 0.13 | 1.52 | 3.11 |
| Return on Capital Employeed (%) | 3.56 | -10.48 | 3.14 | 5.40 | 6.85 |
| Return On Assets (%) | 4.98 | 2.51 | 0.05 | 0.59 | 1.12 |
| Long Term Debt / Equity (X) | 0.01 | 0.13 | 0.22 | 0.19 | 0.29 |
| Total Debt / Equity (X) | 0.11 | 0.36 | 0.44 | 0.41 | 0.55 |
| Asset Turnover Ratio (%) | 2.87 | 3.41 | 2.42 | 3.01 | 3.42 |
| Current Ratio (X) | 2.82 | 0.88 | 0.87 | 0.50 | 0.84 |
| Quick Ratio (X) | 1.35 | 0.53 | 0.62 | 0.29 | 0.65 |
| Inventory Turnover Ratio (X) | 2.35 | 2.63 | 0.99 | 9.28 | 7.42 |
| Interest Coverage Ratio (X) | 8.99 | 2.12 | 7.75 | 5.32 | 3.12 |
| Interest Coverage Ratio (Post Tax) (X) | 1.75 | -3.69 | 1.12 | 1.58 | 1.78 |
| Enterprise Value (Cr.) | 40.05 | 27.54 | 18.24 | 14.60 | 12.26 |
| EV / Net Operating Revenue (X) | 0.44 | 0.28 | 0.24 | 0.14 | 0.12 |
| EV / EBITDA (X) | 11.25 | 24.31 | 4.43 | 7.14 | 7.25 |
| MarketCap / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| Price / BV (X) | 1.30 | 1.81 | 1.04 | 0.84 | 0.49 |
| Price / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| EarningsYield | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 |
After reviewing the key financial ratios for Continental Seeds and Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.40. This value is within the healthy range. It has decreased from 3.64 (Mar 24) to 3.40, marking a decrease of 0.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.44. It has decreased from 97.65 (Mar 24) to 71.44, marking a decrease of 26.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.80. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 2.80, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.83. This value is within the healthy range. It has increased from -1.84 (Mar 24) to 0.83, marking an increase of 2.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.73, marking an increase of 0.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 2. It has increased from 0.66 (Mar 24) to 1.44, marking an increase of 0.78.
- For PBDIT Margin (%), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 10. It has increased from 1.15 (Mar 24) to 3.92, marking an increase of 2.77.
- For PBIT Margin (%), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 10. It has increased from -1.88 (Mar 24) to 1.17, marking an increase of 3.05.
- For PBT Margin (%), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 10. It has increased from 0.81 (Mar 24) to 2.42, marking an increase of 1.61.
- For Net Profit Margin (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 5. It has increased from 0.68 (Mar 24) to 2.01, marking an increase of 1.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 15. It has increased from 5.24 (Mar 24) to 6.43, marking an increase of 1.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.56. This value is below the healthy minimum of 10. It has increased from -10.48 (Mar 24) to 3.56, marking an increase of 14.04.
- For Return On Assets (%), as of Mar 25, the value is 4.98. This value is below the healthy minimum of 5. It has increased from 2.51 (Mar 24) to 4.98, marking an increase of 2.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 24) to 0.01, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.11, marking a decrease of 0.25.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.87. It has decreased from 3.41 (Mar 24) to 2.87, marking a decrease of 0.54.
- For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 2.82, marking an increase of 1.94.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 1.35, marking an increase of 0.82.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.35. This value is below the healthy minimum of 4. It has decreased from 2.63 (Mar 24) to 2.35, marking a decrease of 0.28.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.99. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 8.99, marking an increase of 6.87.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from -3.69 (Mar 24) to 1.75, marking an increase of 5.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 40.05. It has increased from 27.54 (Mar 24) to 40.05, marking an increase of 12.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.44, marking an increase of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 11.25. This value is within the healthy range. It has decreased from 24.31 (Mar 24) to 11.25, marking a decrease of 13.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.30, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Seeds and Chemicals Ltd:
- Net Profit Margin: 2.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.56% (Industry Average ROCE: 16.97%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.43% (Industry Average ROE: 15.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 39.9 (Industry average Stock P/E: 43.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | DTJ-114, DLF Tower B, Jasola, New Delhi Delhi 110025 | info@continentalseeds.co.in http://www.continentalseeds.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pravin Rastogi | Chairman & Managing Director |
| Mrs. Nidhi Gupta | Executive & Women Director |
| Mr. Sachin Rastogi | Non Executive Director |
| Mr. Prashant Rastogi | Independent Director |
| Mr. Gopal Krishan Sharma | Independent Director |
| Mr. Vivek Kumar Mathur | Independent Director |
FAQ
What is the intrinsic value of Continental Seeds and Chemicals Ltd?
Continental Seeds and Chemicals Ltd's intrinsic value (as of 07 November 2025) is 24.11 which is 12.66% higher the current market price of 21.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 23.6 Cr. market cap, FY2025-2026 high/low of 47.5/20.8, reserves of ₹15.68 Cr, and liabilities of 36.62 Cr.
What is the Market Cap of Continental Seeds and Chemicals Ltd?
The Market Cap of Continental Seeds and Chemicals Ltd is 23.6 Cr..
What is the current Stock Price of Continental Seeds and Chemicals Ltd as on 07 November 2025?
The current stock price of Continental Seeds and Chemicals Ltd as on 07 November 2025 is 21.4.
What is the High / Low of Continental Seeds and Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Seeds and Chemicals Ltd stocks is 47.5/20.8.
What is the Stock P/E of Continental Seeds and Chemicals Ltd?
The Stock P/E of Continental Seeds and Chemicals Ltd is 39.9.
What is the Book Value of Continental Seeds and Chemicals Ltd?
The Book Value of Continental Seeds and Chemicals Ltd is 25.8.
What is the Dividend Yield of Continental Seeds and Chemicals Ltd?
The Dividend Yield of Continental Seeds and Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Seeds and Chemicals Ltd?
The ROCE of Continental Seeds and Chemicals Ltd is 4.24 %.
What is the ROE of Continental Seeds and Chemicals Ltd?
The ROE of Continental Seeds and Chemicals Ltd is 2.87 %.
What is the Face Value of Continental Seeds and Chemicals Ltd?
The Face Value of Continental Seeds and Chemicals Ltd is 10.0.